Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy
Karen Johnson, Aaron K. Aragaki, Rebecca D. Jackson, Alex P. Reiner, Per Morten Sandset, Jan Rosing, Anders Erik Astrup Dahm, Frits R. Rosendaal, JoAnn E. Manson, Lisa W. Martin, Simin Liu, Lewis H. Kuller, Mary Cushman, Jacques E. Rossouw (2015). Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy. Arteriosclerosis Thrombosis and Vascular Biology, 36(2), pp. 418-424, DOI: 10.1161/atvbaha.115.306905.
